| scholarly article | Q13442814 |
| P356 | DOI | 10.1093/CID/CIX346 |
| P698 | PubMed publication ID | 28859341 |
| P50 | author | Didier Raoult | Q915676 |
| Pierre-Édouard Fournier | Q21337923 | ||
| Jean-Marc Rolain | Q34572450 | ||
| Grégory Dubourg | Q88357378 | ||
| Hervé Chaudet | Q114412135 | ||
| Cédric Abat | Q114779814 | ||
| P2860 | cites work | Investigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findings | Q24718884 |
| Will 10 Million People Die a Year due to Antimicrobial Resistance by 2050? | Q28033223 | ||
| Epidemic potential of Escherichia coli ST131 and Klebsiella pneumoniae ST258: a systematic review and meta-analysis | Q28073332 | ||
| Mortality and hospital stay associated with resistant Staphylococcus aureus and Escherichia coli bacteremia: estimating the burden of antibiotic resistance in Europe | Q28477449 | ||
| Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. | Q30353189 | ||
| Estimating the impact of school closure on influenza transmission from Sentinel data. | Q30368755 | ||
| EPIMIC: A Simple Homemade Computer Program for Real-Time EPIdemiological Surveillance and Alert Based on MICrobiological Data | Q31031679 | ||
| Predictors of positive blood culture and deaths among neonates with suspected neonatal sepsis in a tertiary hospital, Mwanza-Tanzania | Q33595291 | ||
| Successive emergence of Enterobacter aerogenes strains resistant to imipenem and colistin in a patient | Q33721943 | ||
| Antibiotic resistance-the need for global solutions | Q34386251 | ||
| Burden of Clostridium difficile infection in the United States | Q34464440 | ||
| Real-Time Microbiology Laboratory Surveillance System to Detect Abnormal Events and Emerging Infections, Marseille, France | Q35897061 | ||
| Forgotten antibiotics: an inventory in Europe, the United States, Canada, and Australia | Q37971365 | ||
| Stopping tuberculosis: a biosocial model for sustainable development | Q38619915 | ||
| Access to effective antimicrobials: a worldwide challenge | Q38646928 | ||
| Do we need new antibiotics? | Q38791717 | ||
| Global, regional, and national causes of child mortality in 2000-13, with projections to inform post-2015 priorities: an updated systematic analysis | Q39119101 | ||
| Alice's living croquet theory | Q40736552 | ||
| Anthrax 2001: observations on the medical and public health response | Q42031733 | ||
| Totally resistant tuberculosis: will antileprosy drugs be helpful? | Q45089506 | ||
| The rhizome of the multidrug-resistant Enterobacter aerogenes genome reveals how new "killer bugs" are created because of a sympatric lifestyle | Q48045288 | ||
| Emerging respiratory viruses: is it 'much ado about nothing'? (Shakespeare). | Q51857068 | ||
| In vitro activity of 'old antibiotics' against highly resistant Gram-negative bacteria. | Q53808427 | ||
| P433 | issue | suppl_1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | antibiotic resistance | Q380775 |
| P304 | page(s) | S58-S63 | |
| P577 | publication date | 2017-08-01 | |
| P1433 | published in | Clinical Infectious Diseases | Q5133764 |
| P1476 | title | Evaluating the Clinical Burden and Mortality Attributable to Antibiotic Resistance: The Disparity of Empirical Data and Simple Model Estimations | |
| P478 | volume | 65 |
| Q50032522 | Antibiotic resistance: are we living a nightmare? |
| Q91360180 | Attributable deaths caused by infections with antibiotic-resistant bacteria in France |
| Q89697699 | Characterization of Resistance in Gram-Negative Urinary Isolates Using Existing and Novel Indicators of Clinical Relevance: A 10-Year Data Analysis |
| Q64291023 | Current accounts of antimicrobial resistance: stabilisation, individualisation and antibiotics as infrastructure |
| Q89338599 | Extremely and pandrug-resistant bacteria extra-deaths: myth or reality? |
| Q98177728 | For Whom the Clock Ticks: Clinical Chronobiology for Infectious Diseases |
| Q92637163 | Healthcare Associated Infections: An Interoperable Infrastructure for Multidrug Resistant Organism Surveillance |
| Q92707025 | Improving the estimation of the global burden of antimicrobial resistant infections |
| Q101237290 | Major discrepancy between factual antibiotic resistance and consumption in South of France: analysis of 539,037 bacterial strains |
| Q98733502 | Making of water soluble curcumin to potentiate conventional antimicrobials by inducing apoptosis-like phenomena among drug-resistant bacteria |
| Q90264432 | No global increase in resistance to antibiotics: a snapshot of resistance from 2001 to 2016 in Marseille, France |
| Q92350723 | Perceptions of Antibiotic Therapy Among Nursing Home Residents: Perspectives of Caregivers and Residents in a Mixed Exploratory Study |
| Q99580010 | Plazomicin: a new aminoglycoside in the fight against antimicrobial resistance |
| Q92156716 | Reply to Raoult and Rolain, and to Echols and Tillotson |
| Q58572328 | Role of Institut Hospitalo-Universitaire Méditerranée Infection in the surveillance of resistance to antibiotics and training of students in the Mediterranean basin and in African countries |
| Q89633449 | Strategies to Combat Multidrug-Resistant and Persistent Infectious Diseases |
| Q97546770 | The 2017 global point prevalence survey of antimicrobial consumption and resistance in Canadian hospitals |
| Q90574280 | The Knowledge, Attitudes, and Practices of Community Pharmacists in their Approach to Antibiotic Use: A Nationwide Survey in Italy |
Search more.